Recruiting
Early Phase 1

Effect of Donepezil on Speech Recognition in Cochlear Implant Users

Sponsor:

Vanderbilt University Medical Center

Code:

NCT05438264

Conditions

Bilateral Sensorineural Hearing Loss

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Donepezil

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2024-06-18.